Status:
COMPLETED
Peak Tidal Inspiratory Flow in Infants With Moderate to Severe Acute Viral Bronchiolitis
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Bronchiolitis
Eligibility:
All Genders
Up to 6 years
Phase:
NA
Brief Summary
This aim of this study is to measure the peak tidal inspiratory flow (PTIF), using spirometry, in young infants with moderate to severe acute viral bronchiolitis (AVB). PTIF is important to consider ...
Detailed Description
HFNC allows the administration of a heated and humidified mixture of air and oxygen at high flows. This device has been widely adopted in pediatric intensive care units (PICUs) and for interhospital t...
Eligibility Criteria
Inclusion
- Infants up to 6 months old, with AVB according to conventional clinical criteria;
- Admitted to the department of Neonatal and Pediatric Intensive Care at Arnaud de Villeneuve University Hospital in Montpellier (France);
- Supported with HFNC, according to the department's protocol (2 \< m-WCAS \< 5);
- Not requiring immediate intubation for invasive ventilation;
- Signed parental consent.
Exclusion
- Infant with heart disease, cystic fibrosis or neuromuscular disorder;
- Infant requiring ventilatory support with nasal continuous positive pressure (nCPAP) or with HFNC and without possibility of weaning, including for a few minutes;
- Intolerance of the spirometry mask.
Key Trial Info
Start Date :
November 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03298217
Start Date
November 21 2017
End Date
January 16 2019
Last Update
December 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295